##gff-version 3
##sequence-region Q9H6X2 1 564
Q9H6X2	UniProtKB	Signal peptide	1	32	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9H6X2	UniProtKB	Chain	33	564	.	.	.	ID=PRO_0000002692;Note=Anthrax toxin receptor 1	
Q9H6X2	UniProtKB	Topological domain	33	321	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9H6X2	UniProtKB	Transmembrane	322	342	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9H6X2	UniProtKB	Topological domain	343	564	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9H6X2	UniProtKB	Domain	44	215	.	.	.	Note=VWFA;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00219	
Q9H6X2	UniProtKB	Region	154	160	.	.	.	Note=Interaction with PA	
Q9H6X2	UniProtKB	Compositional bias	360	368	.	.	.	Note=Asp/Glu-rich (highly acidic)	
Q9H6X2	UniProtKB	Compositional bias	506	564	.	.	.	Note=Pro-rich	
Q9H6X2	UniProtKB	Metal binding	52	52	.	.	.	Note=Divalent metal cation;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9H6X2	UniProtKB	Metal binding	54	54	.	.	.	Note=Divalent metal cation;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9H6X2	UniProtKB	Metal binding	118	118	.	.	.	Note=Divalent metal cation;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9H6X2	UniProtKB	Modified residue	362	362	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:17081983;Dbxref=PMID:17081983	
Q9H6X2	UniProtKB	Glycosylation	166	166	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9H6X2	UniProtKB	Glycosylation	184	184	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19349973;Dbxref=PMID:19349973	
Q9H6X2	UniProtKB	Glycosylation	262	262	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9H6X2	UniProtKB	Disulfide bond	39	220	.	.	.	Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20585457;Dbxref=PMID:20585457	
Q9H6X2	UniProtKB	Alternative sequence	268	297	.	.	.	ID=VSP_000446;Note=In isoform 3. NEKPFSVEDTYLLCPAPILKEVGMKAALQV->SKSLQSPWVSSTSGFKEGNSHPCLPARPHT;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9H6X2	UniProtKB	Alternative sequence	298	564	.	.	.	ID=VSP_000447;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9H6X2	UniProtKB	Alternative sequence	315	358	.	.	.	ID=VSP_047863;Note=In isoform 6. THCSDGSILAIALLILFLLLALALLWWFWPLCCTVIIKEVPPPP->FHPSPSSPGSTSQQGTSSLPPSSKAFCLEPKVPALGSLRNFRRC;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:22912819;Dbxref=PMID:22912819	
Q9H6X2	UniProtKB	Alternative sequence	319	333	.	.	.	ID=VSP_000448;Note=In isoform 4. DGSILAIALLILFLL->LHKIASGPTTAACME;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334;Dbxref=PMID:14702039,PMID:15489334	
Q9H6X2	UniProtKB	Alternative sequence	334	564	.	.	.	ID=VSP_000449;Note=In isoform 4. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334;Dbxref=PMID:14702039,PMID:15489334	
Q9H6X2	UniProtKB	Alternative sequence	359	564	.	.	.	ID=VSP_047864;Note=In isoform 6. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:22912819;Dbxref=PMID:22912819	
Q9H6X2	UniProtKB	Alternative sequence	365	368	.	.	.	ID=VSP_000444;Note=In isoform 2. EDDD->NKIK;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:11700562;Dbxref=PMID:11700562	
Q9H6X2	UniProtKB	Alternative sequence	369	564	.	.	.	ID=VSP_000445;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:11700562;Dbxref=PMID:11700562	
Q9H6X2	UniProtKB	Alternative sequence	522	557	.	.	.	ID=VSP_047865;Note=In isoform 5. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:22912819;Dbxref=PMID:22912819	
Q9H6X2	UniProtKB	Natural variant	7	7	.	.	.	ID=VAR_053015;Note=R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14702039;Dbxref=dbSNP:rs28365986,PMID:14702039	
Q9H6X2	UniProtKB	Natural variant	326	326	.	.	.	ID=VAR_063146;Note=In HCI susceptibility%3B expression of FLT1 in hemangioma endothelial cells is markedly reduced compared to controls%3B low FLT1 expression in hemangioma cells is caused by reduced activity of a pathway involving ITGB1%2C ANTXR1%2C KDR and NFATC2IP%3B the mutation disrupts interaction of these molecules in a dominant-negative manner. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18931684;Dbxref=dbSNP:rs119475040,PMID:18931684	
Q9H6X2	UniProtKB	Beta strand	40	50	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Helix	53	58	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Helix	59	72	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Beta strand	78	96	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Helix	99	110	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Helix	120	135	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Beta strand	141	149	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Helix	155	170	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Beta strand	173	179	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Helix	185	188	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Turn	189	191	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Beta strand	192	194	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Helix	195	197	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Beta strand	198	200	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
Q9H6X2	UniProtKB	Helix	201	217	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3N2N	
